Skip links and keyboard navigation

Peripheral Spondyloarthritis - Psoriatic arthritis and Reactive arthritis


Minimum Referral Criteria

  • Category 1
    (appointment within 30 calendar days)
    • New onset, suspected or recently diagnosed inflammatory arthritis
    • Active established inflammatory arthritis requiring escalation of management
  • Category 2
    (appointment within 90 calendar days)
    • Known Spondyloarthritis on established conventional or biologic/targeted synthetic DMARDs (b/tsDMARDs)
  • Category 3
    (appointment within 365 calendar days)
    • No defined category 3 criteria

1. Reason for request Indicate on the referral

  • To establish a diagnosis
  • For treatment or intervention
  • For advice and management
  • For specialist to take over management
  • Reassurance for GP/second opinion
  • For a specified test/investigation the GP can't order, or the patient can't afford or access
  • Reassurance for the patient/family
  • For other reason (e.g. rapidly accelerating disease progression)
  • Clinical judgement indicates a referral for specialist review is necessary

2. Essential referral information Referral will be returned without this

  • History of inflammatory arthritis- symptoms, timing of evolution and rate of deterioration
  • Number and location of swollen, tender joints, tenosynovitis, enthesitis or dactylitis
  • Duration of early morning stiffness (greater or less than 30 minutes)
  • Extra-articular, axial or systemic features
  • Presence of psoriasis, inflammatory bowel disease (IBD), or inflammatory eye disease (uveitis)
  • If on a b/tsDMARD (Specialist only prescribed medication) please state the timeframe for renewal, and last renewed

3. Additional referral information Useful for processing the referral

  • Pain assessment e.g. waking up at night, analgesic consumption, aggravating and relieving factors
  • Interference with activities of daily living and working ability
  • HLA-B27
  • Imaging e.g. XR, MRI/US results of affected joints
  • STI screen/details of preceding infection for suspected reactive arthritis
  • Details of previous treatment/management offered and assessment of efficacy including relevant PBS documentation
  • Other screening previously performed including CXR, HepB, HepC, HIV, QuantiFERON Gold (QFG), Anti-CCP and Rheumatoid factor

4. Request

Last updated: 13 June 2023